SetPoint Medical
David Chernoff has 25 years of molecular diagnostics and biopharmaceutical experience and has served as a translational medicine consultant to more than 40 biopharma and device companies. He has held chief medical officer posts with a number of ventures capital-backed diagnostic and therapeutic companies. He was formerly VP of Corp Technology at Elan Pharma and Medical Director at Chiron Corp.
This person is not in any offices
SetPoint Medical
SetPoint Medical is developing novel bioelectronic medicine therapies to treat those who suffer from autoimmune diseases such as rheumatoid arthritis, Crohn's Disease, and multiple sclerosis.